ADMA Biologics, Inc. (ADMA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
ADMA Biologics relies on diversified, high-margin plasma supply chains. The EV/EBITDA level over the time interval from the GURU.Markets terminal is derived from a chart where the 12.01 metric confirms the current level. The defensive nature of the therapy eliminates the impact of crises, while the transition to generating free cash flow from immunoglobulins minimizes the need for borrowed funds.
admabiologics.com - analytical breakdowns and key metrics (ADMA)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ADMA - Net Income|Projected Future Earnings ADMA Biologics|ADMA - P/E Multiple|Projected Price to Earnings ADMA Biologics|ADMA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple ADMA Corp|ADMA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) ADMA Biologics|ADMA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months admabiologics.com|ADMA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year ADMA Biologics
Initial company analysis:ADMA Bio ADMA
The robotization of plasma purification and the implementation of AI-driven sterility control are enhancing the operational efficiency of ADMA Biologics (ADMA), reducing reliance on the human factor. By analyzing the company's current EV/EBITDA ratio, an investor compares the total enterprise value (market capitalization and debt) with earnings before interest, taxes, depreciation, and amortization, which allows for an objective valuation of assets relative to their ability to generate cash flow.
Competitors of ADMA Biologics
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|protagonist-inc.com (PTGX) - Enterprise Value to EBITDA Ratio|Immunovant (IMVT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kiniksa Pharmaceuticals, Ltd.|Enterprise Value to EBITDA Ratio GRFS|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS - EV/EBITDA Multiple|ABCL: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation TRML|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precigen|Enterprise Value to EBITDA Ratio Pharming Group NV (PHAR)|EV/EBITDA Multiple NKTR|EV/EBITDA Multiple Upstream Pharma (UPB)|Zenas Biopharma Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IMNM|Gossamer Bio - EV/EBITDA Multiple|KALV: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEPN: EV/EBITDA Multiple|PVLA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Savara Inc.|Company Value to EBITDA rigel.com RIGL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ATXS (Astria Therapeutics Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization enGene Bio ENGN|rapt.com (RAPT) - Company Value to EBITDA|Aerovate - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple aclaristx.com (ACRS)|KYTX: EV/EBITDA Multiple|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|CABA (Cabaletta Bio, Inc) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Ventyx Biosciences, Inc (VTYX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|Total Company Value to Operating Income Before Depreciation Ratio avalotx.com|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|EV/EBITDA Multiple Agenus, Inc. AGEN|Climb Bio, Inc. - EV/EBITDA Multiple|ZURA (zurabio.com) - Enterprise Value to Operating Income Before Depreciation|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adagene Inc.|IMA (ImageneBio) - EV/EBITDA Multiple|EV/EBITDA Multiple Shattuck Therapeutics|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple IMUX (Immunic)|Business Value to Operating Income Before Depreciation ATRA|InflaRx GmbH - EV/EBITDA Multiple|XFOR - EV/EBITDA Multiple|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Celularity - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|Akari Therapeutics plc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ENLV|Q32 Bio Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio geovax.com GOVX|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|EV/EBITDA Multiple hcwbiologics.com (HCWB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc. APVO|AIM: Enterprise Value to Operating Income Before Depreciation|Aditxt Corp - EV/EBITDA Multiple|Company Value to EBITDA GRI Bio Corporation|XRTX: EV/EBITDA Multiple|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Enterprise Value to EBITDA Ratio calcimedica.com CALI|EV/EBITDA Multiple AFMD (Affimed N.V.)|EV/EBITDA Multiple Allakos Inc ALLK|HOOK: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IGMS (IGM Biosciences, Inc.)|ITOS: EV/EBITDA Multiple|OCEA (Ocean Biomedical Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
